Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, 7SL, cytoplasmic 166, pseudogene (RN7SL166P) is a pseudogene belonging to the family of 7SL RNA-related sequences[1][9]. The canonical 7SL RNA is an essential non-coding RNA component of the signal recognition particle (SRP), a ribonucleoprotein complex that mediates cotranslational targeting of secretory and membrane proteins to the endoplasmic reticulum[6][8]. However, pseudogenes such as RN7SL166P are typically non-functional, generally not expressed, and do not encode active RNA molecules or proteins[1][9]. 7SL RNA pseudogenes are believed to arise by retrotransposition events and constitute a significant portion of Alu repetitive elements in primate genomes[9][6]. To date, RN7SL166P itself has no recognized biological function, disease role, or relevance as a therapeutic target in human biology or pharmacology[1][9].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 7SL, cytoplasmic 166, pseudogene (RN7SL166P).